chevron_leftBack
As of 24 April 2025, Financière de Tubize S.A. has a market cap of $5.62B USD, ranking #2590 globally and #14 in Belgium. It ranks #223 in the Healthcare sector, and #43 in the Biotechnology industry.
Key Stats
Market Cap
$5.62BUSD
4.96B EUR
Enterprise Value
$5.66BUSD
5.0B EUR
Revenue (TTM)
$15.02KUSD
13.26K EUR
Net Income (TTM)
$102.11MUSD
90.1M EUR
Profit Margin
680K%
PE Ratio
55.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Eric Nys
open_in_new
Employees
3
Founded
1928
Website
financiere-tubize.be
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 3.4% | -2.5% | -23% | -26% | -22% | 18% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
TUB
Financière de Tubize SA
ISIN: BE0003823409
Shares Out.:
Shares Outstanding:
44.513M1
Shares Float:
19.187M2
|
115.20 EUR | |
|
0D53
Financière de Tubize SA
ISIN: BE0003823409
|
109.33 EUR | |
|
1TUB
Financière de Tubize SA
ISIN: BE0003823409
|
113.20 EUR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Financière de Tubize S.A.
Financière de Tubize SA operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. It engages in discovering and developing treatments for patients suffering from serious illnesses that affects immune system or central nervous system. The company was incorporated in 1928 and is based in Brussels, Belgium.
